Application of molecular genetic methods for the diagnosis and prediction of severe dysplasia and cervical cancer
- Authors: Burmenskaya O.V.1, Nazarova N.M.1, Sycheva E.G.1, Prilepskaya V.N.1, Trofimov D.Y.1, Sukhikh G.T.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Issue: No 10 (2021)
- Pages: 85-92
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249394
- DOI: https://doi.org/10.18565/aig.2021.10.85-92
- ID: 249394
Cite item
Abstract
Full Text
![Restricted Access](https://cardiosomatics.orscience.ru/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Olga V. Burmenskaya
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: o_bourmenskaya@oparina4.ru
Dr. Sci. (Bio), Head of the Laboratory of Oncological Genetics
Niso M. Nazarova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: grab2@yandex.ru
Dr. Med. Sci., Senior Researcher
Elena G. Sycheva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: el.bona@mail.ru
PhD, doctor
Vera N. Prilepskaya
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of RussiaDr. Med. Sci., Professor
Dmitry Yu. Trofimov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of RussiaDr. Sci. (Bio), Professor, Director of the Institute of Reproductive Genetics
Gennady T. Sukhikh
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: g_sukhikh@oparina4.ru
Academician RAS, Professor, Director
References
- Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021; 71(3): 209-49. https://dx.doi.org/10.3322/caac.21660.
- Официальный интернет-портал правовой информации. Доступно по: http://publication.pravo.gov.ru/Document/View/0001202011130037
- Bhatla N., Singhal S. Primary HPV screening for cervical cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 2020; 65: 98-108. https://dx.doi.org/10.1016/j.bpobgyn.2020.02.008.
- Cuzick J., Gavel C., Petry K-U., Meijer C.J.L.M., Hoyer H., Ratnam S. et al. Overview of the European and North American studies on HPV testing in primaiy cervical cancer screening. Int. J. Cancer. 2006; 119(5): 1095-101. https://dxdoi.oig/10.1002/ijc.21955.
- Segura S.E., Ramos-Rivera G., Hakima L., Suhrland M., Khader S. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: diagnosis, histological outcomes and human papillomavirus results. Cytopathology. 2019; 30(1): 99-104. https://dx.doi.org/10.1111/cyt.12629.
- Crothers B.A., Jones B.A., Cahill L.A., Moriarty A.T., Mody D.R., Tench W.D. et al. Quality improvement opportunities in gynecologic cytologic-histologic correlations: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 4. Arch. Pathol. Lab. Med. 2013; 137(2): 199-213. https://dx.doi.org/10.5858/arpa.2012-0250-OA.
- Аттоева Д.И., Асатурова А.В., Назарова Н.М., Прилепская В.Н., Стародубцева Н.Л., Шешко П.Л., Уруймагова А.Т. Сопоставление результатов клинических и морфологических методов исследований при ВПЧ-ассоциированных заболеваниях шейки матки (ретроспективное исследование). Гинекология. 2021; 23(1): 78-82. https://dx.doi.org/10.26442/20795696.2021.1.200647.
- Bergeron C., von Knebel Doeberitz M. The role of cytology in the 21st century: the integration of cells and molecules. Acta Cytol. 2016; 60(6): 540-2. https://dx.doi.org/10.1159/000449402.
- Guan P., Howell-Jones R., Li N., Bruni L., de Sanjose S., Franceschi S. et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int. J. Cancer. 2012; 131(10): 2349-59. https://dx.doi.org/10.1002/ijc.27485.
- Bruni L., Diaz M., Castellsague X., Ferrer E., Bosch FX., de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis. 2010; 202(12): 1789-99. https://dx.doi.org/10.1086/657321.
- Gage J.C., Hunt W.C., Schiffman M., Katki H.A., Cheung L.S., Cuzick J. et al. Risk stratification using human papillomavirus testing among women with equivocally abnormal cytology: results from a State-Wide Surveillance Program. Cancer Epidemiol. Biomarkers Prev. 2016; 25(1): 36-42. https://dx.doi.org/10.1158/1055-9965.EPI-15-0669.
- Мельникова Н.В., Боженко В.К., Антонова И.Б., Бабаева Н.А., Яровая Н.Ю., Болотина Н.А., Захаренко М.В., Сенчукова А.П., Акопова Н.Б., Александрова Н.В., Бурменская О.В., Ашрафян Л.А. Цервикальные интра-эпителиальные неоплазии: анализ профиля мРНК в практике жидкостной цитологии. Акушерство и гинекология. 2017; 4: 95-100. https://dx.doi.org/10.18565/aig.2017.4.95-100.
- Burd E.M. Human papillomavirus laboratory testing: the changing paradigm. Clin. Microbiol. Rev. 2016; 29(2): 291-319. https://dx.doi.org/10.1128/CMR.00013-15.
- Li W., Meng Y., Wang Y., Cheng X., Wang C., Xiao S. et al. Association of age and viral factors with high-risk HPV persistence: a retrospective follow-up study. Gynecol. Oncol. 2019; 154(2): 345-53. https://dx.doi.org/10.1016/j.ygyno.2019.05.026.
- Сычева Е.Г., Назарова Н.М., Бурменская О.В., Прилепская В.Н., Трофимов Д.Ю., Сухих Г.Т. Персистенция ВПЧ высокого онкогенного риска и другие молекулярно-генетические предикторы развития цервикальных интраэпителиальных неоплазий. Акушерство и гинекология. 2018; 12: 104-10. https://dx.doi.org/10.18565/aig.2018.12.104-110.
- Rodriguez A.C., Schiffman M., Herrero R., Wacholder S., Hildesheim A., Castle RE. et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natl. Cancer Inst. 2008; 100(7): 513-7. https://dx.doi.org/10.1093/jnci/djn044.
- Weaver B., Shew M., Qadadri B., Tu W., Tong Y., Denski C. et al. Low-level persistence of human papillomavirus 16 DNA in a cohort of closely followed adolescent women. J. Med. Virol. 2011; 83(8): 1362-9. https://dx.doi.org/10.1002/jmv.22116.
- Туранова О.В., Белокриницкая Т.Е., Белозерцева Е.П., Авраченкова А.В. ВПЧ-инфекция: проспективное наблюдение элиминации и оценка факторов риска персистенции. Доктор.Ру. 2019; 4: 31-5. https://dx.doi.org/10.31550/1727-2378-2019-159-4-31-35.
- Rositch A.F., Koshiol J., Hudgens M.G., Razzaghi H., Backes D.M., Pimenta J.M. et al. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int. J. Cancer. 2013; 133(6): 1271-85. https://dx.doi.org/10.1002/ijc.27828.
- Floore A., Hesselink A., Ostrbenk A., Alcaniz E., Rothe B., Pedersen H. et al. Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: results from an international study. J. Clin. Lab. Anal. 2019; 33(4): e22854. https://dx.doi.org/10.1002/jcla.22854.
- De Strooper L.M., Berkhof J., Steenbergen R.D., Lissenberg- Witte B.I., Snijders R.J., Meijer C.J. et al. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up. Int. J. Cancer. 2018; 143(6): 1541-8. https://dx.doi.org/10.1002/ijc.31539.
- Luttmer R., De Strooper L.M., Dijkstra M.G., Berkhof J., Snijders R.J., Steenbergen R.D. et al. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women. Br. J. Cancer. 2016; 115(5): 579-87. https://dx.doi.org/10.1038/bjc.2016.200.
- Moons K.G., Altman D.G., Reitsma J.B., Ioannidis J.R.A., Macaskill R., Steyerberg E.W. et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann. Intern. Med. 2015; 162(1): W1-73. https://dx.doi.org/10.7326/M14-0698.
Supplementary files
![](/img/style/loading.gif)